Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

Jianchun Duan; Wenfeng Fang; Hairong Xu; Jinliang Wang; Yuan Chen; Yi Ding; Xiaorong Dong; Yun Fan; Beili Gao; Jie Hu; Yan Huang; Cheng Huang; Dingzhi Huang; Wenhua Liang; Lizhu Lin; Hui Liu; Zhiyong Ma; Meiqi Shi; Yong Song; Chuanhao Tang; Jialei Wang; Lifeng Wang; Yongfeng Wang; Zhehai Wang; Nong Yang; Yu Yao; Yan Yu; Qitao Yu; Hongmei Zhang; Jun Zhao; Mingfang Zhao; Zhengfei Zhu; Xiaohui Niu; Li Zhang; Jie Wang

doi:10.1016/j.jncc.2023.08.004

Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

Jianchun Duan
, Wenfeng Fang
, Hairong Xu
, Jinliang Wang
, Yuan Chen
, Yi Ding
, Xiaorong Dong
, Yun Fan
, Beili Gao
, Jie Hu
, Yan Huang
, Cheng Huang
, Dingzhi Huang
, Wenhua Liang
, Lizhu Lin
, Hui Liu
, Zhiyong Ma
, Meiqi Shi
, Yong Song
, Chuanhao Tang

Jialei Wang, Lifeng Wang, Yongfeng Wang, Zhehai Wang, Nong Yang, Yu Yao, Yan Yu, Qitao Yu, Hongmei Zhang, Jun Zhao, Mingfang Zhao, Zhengfei Zhu, Xiaohui Niu, Li Zhang, Jie Wang

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.

Original language	English
Pages (from-to)	256-265
Number of pages	10
Journal	Journal of the National Cancer Center
Volume	3
Issue number	4
DOIs	https://doi.org/10.1016/j.jncc.2023.08.004
State	Published - Dec 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Bone metastasis
Bone-modifying drugs
Lung cancer
Multi-disciplinary therapy

Access to Document

10.1016/j.jncc.2023.08.004

Cite this

Duan, J., Fang, W., Xu, H., Wang, J., Chen, Y., Ding, Y., Dong, X., Fan, Y., Gao, B., Hu, J., Huang, Y., Huang, C., Huang, D., Liang, W., Lin, L., Liu, H., Ma, Z., Shi, M., Song, Y., ... Wang, J. (2023). Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition). Journal of the National Cancer Center, 3(4), 256-265. https://doi.org/10.1016/j.jncc.2023.08.004

@article{3bb83d79c61f4758b33cf8c2c3a0c71a,

title = "Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)",

abstract = "Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50\% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.",

keywords = "Bone metastasis, Bone-modifying drugs, Lung cancer, Multi-disciplinary therapy",

author = "Jianchun Duan and Wenfeng Fang and Hairong Xu and Jinliang Wang and Yuan Chen and Yi Ding and Xiaorong Dong and Yun Fan and Beili Gao and Jie Hu and Yan Huang and Cheng Huang and Dingzhi Huang and Wenhua Liang and Lizhu Lin and Hui Liu and Zhiyong Ma and Meiqi Shi and Yong Song and Chuanhao Tang and Jialei Wang and Lifeng Wang and Yongfeng Wang and Zhehai Wang and Nong Yang and Yu Yao and Yan Yu and Qitao Yu and Hongmei Zhang and Jun Zhao and Mingfang Zhao and Zhengfei Zhu and Xiaohui Niu and Li Zhang and Jie Wang",

note = "Publisher Copyright: {\textcopyright} 2023 Chinese National Cancer Center",

year = "2023",

month = dec,

doi = "10.1016/j.jncc.2023.08.004",

language = "英语",

volume = "3",

pages = "256--265",

journal = "Journal of the National Cancer Center",

issn = "2096-8663",

publisher = "Chinese National Cancer Center",

number = "4",

}

Duan, J, Fang, W, Xu, H, Wang, J, Chen, Y, Ding, Y, Dong, X, Fan, Y, Gao, B, Hu, J, Huang, Y, Huang, C, Huang, D, Liang, W, Lin, L, Liu, H, Ma, Z, Shi, M, Song, Y, Tang, C, Wang, J, Wang, L, Wang, Y, Wang, Z, Yang, N, Yao, Y, Yu, Y, Yu, Q, Zhang, H, Zhao, J, Zhao, M, Zhu, Z, Niu, X, Zhang, L & Wang, J 2023, 'Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)', Journal of the National Cancer Center, vol. 3, no. 4, pp. 256-265. https://doi.org/10.1016/j.jncc.2023.08.004

TY - JOUR

T1 - Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

AU - Duan, Jianchun

AU - Fang, Wenfeng

AU - Xu, Hairong

AU - Wang, Jinliang

AU - Chen, Yuan

AU - Ding, Yi

AU - Dong, Xiaorong

AU - Fan, Yun

AU - Gao, Beili

AU - Hu, Jie

AU - Huang, Yan

AU - Huang, Cheng

AU - Huang, Dingzhi

AU - Liang, Wenhua

AU - Lin, Lizhu

AU - Liu, Hui

AU - Ma, Zhiyong

AU - Shi, Meiqi

AU - Song, Yong

AU - Tang, Chuanhao

AU - Wang, Jialei

AU - Wang, Lifeng

AU - Wang, Yongfeng

AU - Wang, Zhehai

AU - Yang, Nong

AU - Yao, Yu

AU - Yu, Yan

AU - Yu, Qitao

AU - Zhang, Hongmei

AU - Zhao, Jun

AU - Zhao, Mingfang

AU - Zhu, Zhengfei

AU - Niu, Xiaohui

AU - Zhang, Li

AU - Wang, Jie

PY - 2023/12

Y1 - 2023/12

N2 - Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.

AB - Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.

KW - Bone metastasis

KW - Bone-modifying drugs

KW - Lung cancer

KW - Multi-disciplinary therapy

UR - https://www.scopus.com/pages/publications/85172267656

U2 - 10.1016/j.jncc.2023.08.004

DO - 10.1016/j.jncc.2023.08.004

M3 - 文章

AN - SCOPUS:85172267656

SN - 2096-8663

VL - 3

SP - 256

EP - 265

JO - Journal of the National Cancer Center

JF - Journal of the National Cancer Center

IS - 4

ER -

Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this